Men and women of Ashkenazi Jewish decent have a 1 in 40 chance of carrying the BRCA1 or BRCA2 gene mutation. This puts them at greater risk for both breast and ovarian cancers. Learn about the risks and how these genes play into the Jewish identify.
Hear from a panel of Jewish BRCA-positive cancer survivors, and keynote speaker Dr. Dana Kostiner-Simpson, MD, who is an MD and geneticist from Kaiser Permanente.
RSVP at www.oregonjcc.org
Ovarian Cancer Alliance of Oregon and Southwest Washington
PMB 243 Suite 103, 16420 SE McGillivray
Vancouver, WA 98683-3461
(877) 682-2679 firstname.lastname@example.org
We are a registered 501(c)(3) Non-Proft Corporation. EIN: 20-2558493Copyright © 2005-2019 Ovarian Cancer Alliance of Oregon and Southwest Washington. All rights reserved.